UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Aug 20, 2026
Sale
Calculated transaction value
$231.31K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Aug 19, 2026
Public filing date
Aug 20, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$529.14
Aug 19, 2026
Close before public filing
$529.14
Aug 19, 2026
Return since public filing
-6.05%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 441 shares @ $524.51
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000124
Filing cohort
Transactions in this filing
Showing 14 of 14
Trades
14
Issuers
1
Estimated value
$6.29M
Buys / sales
0 / 12
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR Current | Sale | Aug 19, 2026 | $231.31K |
| United Therapeutics Corp UTHR | Sale | Aug 19, 2026 | $470.41K |
| United Therapeutics Corp UTHR | Sale | Aug 19, 2026 | $42.82K |
| United Therapeutics Corp UTHR | Exercise | Aug 19, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Aug 19, 2026 | $125.4K |
| United Therapeutics Corp UTHR | Sale | Aug 19, 2026 | $661.89K |
| United Therapeutics Corp UTHR | Sale | Aug 19, 2026 | $1.11M |
| United Therapeutics Corp UTHR | Sale | Aug 19, 2026 | $1.13M |
| United Therapeutics Corp UTHR | Sale | Aug 19, 2026 | $634.3K |
| United Therapeutics Corp UTHR | Sale | Aug 19, 2026 | $348.98K |
| United Therapeutics Corp UTHR | Sale | Aug 19, 2026 | $106.73K |
| United Therapeutics Corp UTHR | Sale | Aug 19, 2026 | $42.53K |
| United Therapeutics Corp UTHR | Sale | Aug 19, 2026 | $106.53K |
| United Therapeutics Corp UTHR | Exercise | Aug 19, 2026 | $0 |